Table: Modalis Therapeutics -2020 group results

Modalis Therapeutics

12/02/2021 06:01

Feb 12 (Reuters)- 
          Modalis Therapeutics Corporation 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2020    Dec 31, 2019   Dec 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          342 mln         644 mln                               
               (-46.9 pct)    (+887.0 pct)                             
  Operating   loss 398 mln       157 mln                               
  Recurring   loss 439 mln       146 mln                               
  Net
  Net         loss 448 mln       140 mln                               
  EPS        loss 17.02 yen     5.96 yen                               
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Modalis Therapeutics Corporation.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T